HIGHLIGHTS
- who: Christopher Elnan Kvistad from the Department of Neurology, Haukeland University Hospital, Bergen, Norway, Tissue Engineering Group, Department of University Hospital La Paz, Spain have published the research: Safety and Clinical Efficacy of Mesenchymal Stem Cell Treatment in Traumatic Spinal Cord Injury, Multiple Sclerosis and Ischemic Stroke - A Systematic Review and Meta-Analysis, in the Journal: (JOURNAL)
- what: In this systematic review and meta-analysis, the authors aimed to assess safety and clinical effect of MSC treatment in traumatic spinal cord injury (TSCI), multiple_sclerosis (MS) and ischemic stroke (IS).
SUMMARY
Eligibility . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.